Citation Impact
Citing Papers
Matrix Protein CCN1 Is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis
2009 Standout
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Minority Stress Factors Associated With Depression and Anxiety Among Transgender and Gender-Nonconforming Youth
2018 Standout
Healthcare avoidance due to anticipated discrimination among transgender people: A call to create trans-affirmative environments
2020 Standout
Quality of life improves early after gender reassignment surgery in transgender women
2016 Standout
Characteristics of Referrals for Gender Dysphoria Over a 13-Year Period
2016
Global health burden and needs of transgender populations: a review
2016 Standout
Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone‐refractory prostate cancer
2008
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
2011
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
2013
Transgender youth and suicidal behaviors: Applying the interpersonal psychological theory of suicide
2016
Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
2014
Mental Health of Transgender Youth in Care at an Adolescent Urban Community Health Center: A Matched Retrospective Cohort Study
2015
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
2011
Therapeutic potential of PARP inhibitors for metastatic breast cancer
2011
Children and Adolescents and Digital Media
2016 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
Small Cell Lung Cancer
2008
Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions
2015 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Diagnosing the decline in pharmaceutical R&D efficiency
2012 Standout
Vinflunine: clinical perspectives of an emerging anticancer agent
2008
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Intersectionality Research for Transgender Health Justice: A Theory-Driven Conceptual Framework for Structural Analysis of Transgender Health Inequities
2019 Standout
Barriers to Gender Transition-Related Healthcare: Identifying Underserved Transgender Adults in Massachusetts
2017 Standout
Transgender Medicare Beneficiaries and Chronic Conditions: Exploring Fee-for-Service Claims Data
2017 Standout
Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity
2017 StandoutNobel
Mental Health of Transgender Children Who Are Supported in Their Identities
2016
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
2016 StandoutNobel
Legal Protections in Public Accommodations Settings: A Critical Public Health Issue for Transgender and Gender‐Nonconforming People
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Works of Lisa Simons being referenced
A Phase II Trial of Gemcitabine/Carboplatin with or Without Trastuzumab in the First-Line Treatment of Patients with Metastatic Breast Cancer
2008
Weekly Docetaxel and Bortezomib as First-Line Treatment for Patients with Hormone-Refractory Prostate Cancer: A Minnie Pearl Cancer Research Network Phase II Trial
2007
Parental Support and Mental Health Among Transgender Adolescents
2013
Irinotecan, Carboplatin, and Imatinib in Untreated Extensive-Stage Small-Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network
2007
29. The Relationship Between Parental Support and Depression and Suicidality in Transgender Adolescents
2012
Preliminary results of a multicenter phase II trial of vinflunine (with trastuzumab in HER2+ pts) as first-line treatment in metastatic breast cancer
2007
Baseline Physiologic and Psychosocial Characteristics of Transgender Youth Seeking Care for Gender Dysphoria
2015